Agilent Technologies (A) Stock Down 3% Despite Better Than Expected Q4 Results & Guidance
Get Alerts A Hot Sheet
Price: $150.86 +0.59%
EPS Growth %: +8.8%
Financial Fact:
Diluted (in shares): 328M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +8.8%
Financial Fact:
Diluted (in shares): 328M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Agilent Technologies (NYSE: A) shares were trading 3% lower after-hours, despite the company’s reported Q4 EPS of $1.21, which came better than the consensus estimate of $1.17. Quarterly revenue grew 12% year-over-year to $1.66 billion, in line with the consensus estimate.
The company expects Q1/22 EPS to range from $1.16 to $1.18 (vs. Street’s $1.02) and revenue in the range of $1.64-1.66 billion (vs. Street’s $1.47 billion). For the full 2022-year, the company expects EPS to be between $4.76 and $4.86 (vs. Street’s $4.24) and revenue of $6.65-6.73 billion (vs. Street’s $6.01 billion).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agilent launches FDA-cleared S540MD slide scanner in the U.S.
- Palo Alto Networks, Sandisk, Arista added to S&P 100
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share